<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Corbel;
panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
{font-family:"Book Antiqua";
panose-1:2 4 6 2 5 3 5 3 3 4;}
@font-face
{font-family:"Baskerville Old Face";
panose-1:2 2 6 2 8 5 5 2 3 3;}
@font-face
{font-family:Elephant;
panose-1:2 2 9 4 9 5 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1872374946;
mso-list-type:hybrid;
mso-list-template-ids:1146630522 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level2
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level3
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level4
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level5
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level6
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level7
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level8
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level9
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal">See Callaway Answers below:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal">Thanks,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Aaron Enloe<o:p></o:p></p>
<p class="MsoNormal">Supervising Health Physicist<o:p></o:p></p>
<p class="MsoNormal">Radiation Protection<o:p></o:p></p>
<p class="MsoNormal">573-592-9286<o:p></o:p></p>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b>From:</b> Global <global-bounces@list.rpalara.org> <b>On Behalf Of
</b>Douthwaite, Andrew W via Global<br>
<b>Sent:</b> Monday, August 15, 2022 7:14 AM<br>
<b>To:</b> global@list.rpalara.org<br>
<b>Subject:</b> [EXTERNAL] [Global] Emergent Dose Banks During Outages<o:p></o:p></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><span style="font-size:13.5pt;font-family:"Arial",sans-serif;color:crimson">EXTERNAL SENDER</span></b>
<b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#070707">STOP.THINK.QUESTION.</span></b><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#070707"><br>
Verify unexpected requests before opening links or attachments.</span><o:p></o:p></p>
<div class="MsoNormal" align="center" style="text-align:center">
<hr size="2" width="100%" align="center">
</div>
<p class="MsoNormal">Peers<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Salem is looking to benchmark industry best practices for establishing emergent dose banks during refuel outages. My questions are:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<ol style="margin-top:0in" start="1" type="1">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo2">Do you allocate a bank of estimated dose to account for emergent dose during refuel outages?
<span style="color:red">It is not preoceduralized but we have been adding approximately 5% to our refuel budgets for emergent dose. Last refuel that was 2.6 Rem</span><o:p></o:p></li><ol style="margin-top:0in" start="1" type="a">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level2 lfo2">If so, how much is it, in Person-Rem?<o:p></o:p></li><li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level2 lfo2">What percentage of the overall estimate is your bank?<o:p></o:p></li></ol>
</ol>
<p class="MsoNormal"><o:p> </o:p></p>
<ol style="margin-top:0in" start="2" type="1">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo2">How much emergent dose do you typically see during a refuel outage, in Person-Rem?
<span style="color:red">We typically do not see much in the way of emergent dose. Typically it is scaffold, snubber inspections and the occasional emergent valve or another component. Last refuel it was less than the 2.6 rem, approximately 1-2 rem on average</span><o:p></o:p></li><ol style="margin-top:0in" start="1" type="a">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level2 lfo2">What percentage is that of the overall exposure your station sees during a refuel outage?
<span style="color:red">It accounts for less than 5 percent of the overall dose budget for the refuel typically 2 percent.
</span><o:p></o:p></li></ol>
</ol>
<p class="MsoListParagraph"><o:p> </o:p></p>
<ol style="margin-top:0in" start="3" type="1">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo2">How do you keep track of your emergent dose?
<span style="color:red">Emergent dose it tracked by RWP. We write new RWP's for the emergent work and tag the RWPs as emergent with our emergent alara review number. </span><o:p></o:p></li></ol>
<p class="MsoNormal"><o:p> </o:p></p>
<ol style="margin-top:0in" start="4" type="1">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo2">Do you use a separate RWP/Task/ALARA Plan for the purposes of tracking emergent dose?
<span style="color:red">See above</span><o:p></o:p></li></ol>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><i><span style="font-size:13.0pt;font-family:"Baskerville Old Face",serif;color:black">"Life is about ups and downs. Hills and valleys. But if you stick with it... everything seems to work out." – Wally West<o:p></o:p></span></i></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:black">Andrew Douthwaite
</span></b><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:#FF6600">|</span><b><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:navy">
</span></b><b><span style="font-size:10.0pt;font-family:Wingdings;color:#FF6600">R</span></b><b><span style="font-size:10.0pt;font-family:"Elephant",serif;color:black">PSEG
</span></b><b><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:#FF6600">Nuclear LLC</span></b><b><span style="font-size:10.0pt;font-family:"Book Antiqua",serif;color:#FF6600">
</span></b><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:#FF6600">|</span><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:red">
</span><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:#404040">Salem Radiation Protection</span><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:#404040"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Corbel",sans-serif;color:#404040">P.O. Box 236, Hancocks Bridge, NJ 08038-1236<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:6.0pt;font-family:"Corbel",sans-serif;color:#404040"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:9.0pt;font-family:"Arial",sans-serif;color:#404040">Office: +1 856-339-2326 | Fax: +1 856-339-1506</span><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D"><a href="mailto:Andrew.Douthwaite@pseg.com"><span style="color:blue">Andrew.Douthwaite@pseg.com</span></a></span><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal">The information contained in this e-mail, including any attachment(s), is intended solely for use by the named addressee(s). If you are not the intended recipient, or a person designated as responsible for delivering such messages to the
intended recipient, you are not authorized to disclose, copy, distribute or retain this message, in whole or in part, without written authorization from PSEG. This e-mail may contain proprietary, confidential or privileged information. If you have received
this message in error, please notify the sender immediately. This notice is included in all e-mail messages leaving PSEG. Thank you for your cooperation.<o:p></o:p></p>
</div>
</div>
This communication and any attachments may be privileged and/or confidential and protected from disclosure, and are otherwise the exclusive property of Ameren Corporation and its affiliates (Ameren) or the intended recipient. If you are not the intended recipient,
you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. Note that any views or opinions presented in this message do not necessarily represent those of Ameren. All e-mails are subject to Ameren
policies. If you have received this in error, please notify the sender immediately by replying to the message and deleting the material from any computer.
</body>
</html>